Go Deep
Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,136 | 25.8 | 4.64 | 0.11 | 383.07 |
| Oct 2026 | 23,138 | 25.8 | 4.63 | 0.11 | 383.49 |
| Oct 2026 | 22,645 | 28.0 | 5.02 | 0.11 | 415.38 |
| Oct 2026 | 22,647 | 28.0 | 5.02 | 0.11 | 414.35 |
| Oct 2026 | 23,118 | 25.9 | 4.65 | 0.11 | 383.30 |
| Oct 2026 | 22,905 | 26.8 | 4.82 | 0.11 | 398.90 |
Hansoh Pharmaceutical Group Company Limited Quarterly Results
Quarterly data isn't available for this company right now.
Hansoh Pharmaceutical Group Company Limited Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 15,028,324,000.0 | 12,260,814,000.0 | 10,103,806,000.0 | 9,382,410,000.0 |
| Net Profit | 5,555,461,000.0 | 4,371,825,000.0 | 3,277,503,000.0 | 2,583,747,000.0 |
| EPS | 0.9 | 0.7 | 0.6 | 0.4 |
Hansoh Pharmaceutical Group Company Limited Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 39,900,351,000.0 | 31,657,849,000.0 | 33,039,079,000.0 | 30,001,879,000.0 | — |
| Total Liabilities | 4,535,900,000.0 | 2,977,935,000.0 | 7,244,306,000.0 | 7,354,935,000.0 | — |
| Total Equity | 35,364,451,000.0 | 28,679,914,000.0 | 25,794,773,000.0 | 22,646,944,000.0 | — |
Owes vs Owns
Hansoh Pharmaceutical Group Company Limited owed ¥0.11 for every ¥1 it owned in Dec 2025, down from ¥0.25 in Dec 2022.
| Period | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Owes vs Owns | 0.11× | 0.09× | 0.22× | 0.25× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Hansoh Pharmaceutical Group Company Limited Assets & Liabilities Breakdown (CNY millions)
What it owns — Dec 2025
Cash & short-term investments 79.1%Receivables 7.6%Inventory 1.5%Fixed assets (tangible) 8.0%Intangible assets 0.9%Long-term investments 1.9%Other assets 0.9%
How it's funded — Dec 2025
Payables 0.8%Other liabilities 10.3%Shareholders' equity 88.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 31,566.3 | 23,386.3 | 24,857.1 | 21,623.5 |
| Receivables | 3,038.5 | 3,127.5 | 3,209.6 | 3,534.0 |
| Inventory | 608.9 | 651.2 | 575.8 | 447.9 |
| Fixed assets (tangible) | 3,209.9 | 3,268.5 | 3,293.7 | 3,483.2 |
| Intangible assets | 362.6 | 245.3 | 177.4 | 33.4 |
| Long-term investments | 772.5 | 702.3 | 0.0 | 241.1 |
| Other assets | 341.6 | 276.8 | 925.5 | 638.9 |
| Liabilities & equity | ||||
| Short-term debt | 40.5 | 40.9 | 4,183.2 | 0.0 |
| Long-term debt | 47.6 | 0.0 | 39.7 | 4,282.7 |
| Payables | 334.3 | 217.9 | 163.8 | 222.3 |
| Other liabilities | 4,113.5 | 2,719.2 | 2,857.6 | 2,849.9 |
| Shareholders' equity | 35,364.5 | 28,679.9 | 25,794.8 | 22,646.9 |
| Net tangible assets | 35,001.8 | 28,434.6 | 25,617.4 | 22,613.5 |
Hansoh Pharmaceutical Group Company Limited Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 6,738,246,000.0 | 3,862,355,000.0 | 3,116,468,000.0 | 2,741,205,000.0 | — |
| Investing Activities | -7,154,568,000.0 | -1,391,792,000.0 | 1,073,972,000.0 | -5,935,073,000.0 | — |
| Financing Activities | 1,554,120,000.0 | -6,065,945,000.0 | -753,695,000.0 | -818,144,000.0 | — |